Skip to ContentSkip to Navigation
Practical matters How to find us E.A.M. Festen

Publications

Hepcidin and Iron Status in Patients With Inflammatory Bowel Disease Undergoing Induction Therapy With Vedolizumab or Infliximab

Biomarkers of neutrophil activity and extracellular matrix turnover predict long-term response to vedolizumab in patients with Crohn's disease

Cigarette smoke increases risk for colorectal neoplasia in inflammatory bowel disease

Gut microbiome dysbiosis is associated with increased mortality after solid organ transplantation

Gut mucosa dissociation protocols influence cell type proportions and single-cell gene expression levels

In-depth characterisation of the serum antibody epitope repertoire in Inflammatory Bowel Disease by high-throughput phage-displayed immunoprecipitation sequencing

Long-Term Dietary Patterns Are Reflected in the Plasma Inflammatory Proteome of Patients with Inflammatory Bowel Disease

Mucosal microbiota modulate host intestinal immune signatures in Inflammatory Bowel Disease

Proteomic analyses do not reveal subclinical inflammation in fatigued patients with clinically quiescent inflammatory bowel disease

Proteomic analyses do not reveal subclinical inflammation in fatigued patients with quiescent Inflammatory Bowel Disease

Read more

Press/media

Effectiviteit van medicijnen voorspellen bij chronische darmziekte colitis ulcerosa